These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Inert placebo versus active medication. Patient blindability in clinical pharmacological trials. Bystritsky A, Waikar SV. J Nerv Ment Dis; 1994 Sep; 182(9):485-7. PubMed ID: 8083675 [Abstract] [Full Text] [Related]
27. Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group. Arch Gen Psychiatry; 1991 Aug; 48(8):730-8. PubMed ID: 1883256 [Abstract] [Full Text] [Related]
30. A preliminary report on clinical response and plasma levels of clomipramine and desmethylclomipramine in obsessive-compulsive neurosis. Stern RS, Cobb JP, Marks IM, Jones RB, Luscombe DK. Postgrad Med J; 1977 Aug; 53 Suppl 4():97-103. PubMed ID: 341110 [No Abstract] [Full Text] [Related]
31. Clomipramine for obsessive compulsive disorder. Med Lett Drugs Ther; 1988 Nov 04; 30(778):102-4. PubMed ID: 3050411 [No Abstract] [Full Text] [Related]
39. Early response with clomipramine in obsessive compulsive disorder--a placebo controlled study. Montgomery SA, Montgomery DB, Fineberg N. Prog Neuropsychopharmacol Biol Psychiatry; 1990 Aug 04; 14(5):719-27. PubMed ID: 2293252 [Abstract] [Full Text] [Related]
40. [Double-blind comparative study of alprazolam (Xanax) and amitriptyline in the treatment of anxiety associated with depression]. Bernardi F, Cairoli S, D'Aurizio C, De Rosa A, Grasso A, Sannino V, Savoldi F, Sorge F, Casadei GL. Minerva Psichiatr; 1988 Aug 04; 29(4):203-10. PubMed ID: 3074234 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]